Emma Simonsen

Emma Simonsen is a Researcher at the Institute for Health Services Research within the Clinical Pharmacology, Pharmacy and Environmental Medicine department at the University of Southern Denmark. Her work bridges pharmacology, toxicology, and biomarker research, with a focus on drug-induced neurological complications and cancer therapy.

• Research Focus: Pharmacology, Toxicology, and Biomarker Development
• Key Collaborations: Danish-Norwegian cohort studies

Her recent publications highlight investigations into paclitaxel-induced peripheral neuropathy and semaglutide-related optic neuropathy, emphasizing translational approaches and clinical pharmacology. She utilizes biomarkers like neurofilament light chain to assess drug toxicity and treatment outcomes.

Emma collaborates with cross-institutional teams on topics spanning neurotoxicity, diabetes medications, and chemotherapy risks, as evidenced by her co-authored articles. Her research integrates pharmacological, oncological, and epidemiological perspectives to address drug safety challenges.